Platform
Features
0 followers
Cyanvac develops vaccines using a proprietary transformational parainfluenza virus 5 (PIV5)-based vector.
Industries
Headquarters
Links
Fred C. Davison
This company has no teams yet
Merck
224 followers
AbbVie
187 followers
Takeda Oncology
14 followers
Abbott
286 followers
Incyte
16 followers
OraSure Technologies
2 followers
Novavax
9 followers
Pfizer
506 followers
Amgen
226 followers
Elanco
21 followers
Taiho Oncology, Inc.
Explore companies